The aim of this opportunity is to support the development of novel preventive, diagnostic and therapeutic approaches and products for diabetes and cardiovascular disease
Up to $47M.
Submission requirements & due date
- Applications must be submitted for internal review by 15 April 2020
- Please email firstname.lastname@example.org if you are considering applying for this scheme.
- See also: Submitting an application to Research Services for review